Mary Elizabeth Kreider, MD, MSCE
Professor of Clinical Medicine (Pulmonary, Allergy and Critical Care)
Program Director, Pulmonary and Critical Care Fellowship, Hospital of the University of Pennsylvania
Director ILD Program, Perelman School of Medicine of the University of Pennsylvania
Vice Chief for Education and Faculty Development for Pulmonary and Critical Care, Division of Pulmonary, Allergy and Critical Care, University of Pennsylvania
Department: Medicine
Contact information
Hospital of the University of Pennsylvania
Pulmonary, Allergy and Critical Care Medicine Division
838 Gates Bldg
Philadelphia, PA 19104
Pulmonary, Allergy and Critical Care Medicine Division
838 Gates Bldg
Philadelphia, PA 19104
Office: 215-614-1939
Fax: 215-614-0869
Fax: 215-614-0869
Education:
B.A. (Political Science, Sociology)
Swarthmore College, 1992.
M.D. (Medicine)
University of Pennsylvania School of Medicine, 1997.
M.S.C.E. (Clinical Epidemiology)
University of Pennsylvania School of Medicine Center for Clinical Epidemiology and Biostatistics, 2003.
Permanent linkB.A. (Political Science, Sociology)
Swarthmore College, 1992.
M.D. (Medicine)
University of Pennsylvania School of Medicine, 1997.
M.S.C.E. (Clinical Epidemiology)
University of Pennsylvania School of Medicine Center for Clinical Epidemiology and Biostatistics, 2003.
Description of Research Expertise
A recipient of a Masters degree in Clinical Epidemiology and Biostatistics, Dr. Kreider studies risk factors for both the development of Interstitial Lung Diseases and for poor outcome. She is an active participant in several drug trials for patients both with pulmonary fibrosis and sarcoidosis. In addition she participates in studies of patients with Lymphangioleiomyomatosis (LAM).Description of Clinical Expertise
Dr. Kreider is the Director of the Interstitial Lung Disease Program and has expertise in the evaluation and treatment of patients with diffuse parenchymal lung diseases. In addition she serves as the Director of the Lymphangioleiomyomatosis (LAM) Clinic at Penn. Dr. Kreider’s clinical interests include patients with Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis associated with Collagen Vascular Disease, Chronic Hypersensitivity Pneumonitis, Sarcoidosis and cystic lung disease including LAM.Selected Publications
Winterbottom CJ, Shah RJ, Patterson KC, Kreider ME, Panettierri RA Jr, Rivera-Lebron B, Miller WT, Litzky LA, Penning TM, Heinlen, Jackson T, Localio AR, Chritie JD: Exposure to ambient particulate matter is associated with accelerated functional decline in Idiopathic Pulmonary Fibrosis. Chest 153(5): 1221-1228, 2018.George MD, Shah R, Kreider M, Miller WT Jr, Merkel PA, Werth VP. : Pulmonary function tests, interstitial lung disease, and lung function decline in outpatients with classic and clinically amyopathic dermatomyositis. Br J Dermatol 176(1): 262-264, 2017.
Patterson KC, Shah RJ, Porteous MK, Christie JD, D'Errico C, Chadwick M, Triano M, Deshpande C, Rossman MD, Litzky LA, Kreider ME, Miller WT Jr: Interstitial Lung Disease in the Elderly. Chest 151(4): 838-844, 2017.
Kassutto SM, Dine CJ, Kreider M, Shah RJ: Changing the ambulatory training paradigm: design and implementation of an outpatient pulmonary fellowship curriculum. Ann Am Thorac Soc 13(4): 540-544, Apr 2016.
Porteous MK, Rivera-Lebron BN, Kreider ME, Lee J, Kawut SM: Determinants of six-minute walk distance in patients with idiopathic pulmonary fibrosis undergoing lung transplant evaluation. Pulm Circ 6(1): 30-36, Mar 2016.
Kreider ME and Rossman MD.: Beryllium and Heard Metal Lung Disease. Fishman's Textbook of Pulmonary Diseases and Disorders, 5th ed. McGraw Hill Press, Page: 1334-1341, 2015.
Kreider M, Highland K: Pulmonary Involvement in Sjogren's Syndrome. Semin Respir Crit Care Med 35(2): 255-264, 2014.
Kreider ME: Pulmonary Function Testing. Scientific American Medicine [online] Nabel EG (eds.). Decker Intellectual Properties, 2014.
Rivera-Lebron BN, Forfia P, Kreider M, Lee J, Holmes J, Kawut SM.: Echocardiographic and Hemodynamic Predictors of Mortality in Idiopathic Pulmonary Fibrosis. Chest 144(2): 564-570, 2013.
Kreider, M: Lung Cancer in Idiopathic Pulmonary Fibrosis. Curr Respir Care Rep 2(4): 248-253, December 2013.
Dine, CJ, Kreider, ME: Pulmonary Complication of Collagen Vascular Diseases. Clinical Decision Support: Pulmonary and Sleep Medicine - www.decisionsupportinmedicine.com/DSM/a/templates/28 (accessed April 16, 2013) April 2013.
Song G, Barbosa EM, Tustison ND, Gefter WB, Kreider ME, Gee JC, Torigian DA: Comparative Study of HRCT Image Metrics and PFT Values for Characterization of ILD and COPD. Academic Radiology 19(7): 857-64, Jul 2012.
Kreider ME, Hadjiliadis D, Kotloff RM: Candidate Selection, Timing of Listing, and Choice of Procedure for Lung Transplantation. Clinics in Chest Medicine 32(2): 199-211, Jan 2011.
Morganroth PA, Kreider ME, Werth VP: Mycophenolate Mofetil for Interstitial Lung Disease in Dermatomyositis. Arthritis Care and Research 62(10): 1496-1501, Oct 2010.
Barbosa EM, Song G, Tustison N, Kreider ME, Gee J, Gefter WB, Torigian DA.: Computational Analysis of Thoracic Multidetector Row HRCT for Segmentation and Quantification of Small Airway Trapping and Emphysema for Obstructive Pulmonary Disease. Academic Radiology 18: 1258-1269, 2011.
Munson JC, Kreider ME, Chen Z, Christie JD, Kimmel SE: Use of Corticosteroids and Cytotoxic Agents in the Initial Management of IPF: Effect of Treatment Guidelines Over Time. British Journal of Clinical Pharmacology 70(1): 118-125, Jul 2010.
Morganroth PA, Kreider ME, Werth VP: Interstitial Lung Disease in Classic and Amyopathic Dermatomyositis: a Retrospective Study with Screening Recommendations. Archives of Dermatology 146(7): 729-738, May 2010.
Lange NE, Mulholland M, Kreider ME: Spirometry: Don't Blow It! Chest 136(2): 608-14, Aug 2009.
Kreider ME, Hansen-Flaschen J, Ahmad NN, Rossman MD, Kaiser LR, Kucharczuk JC, Shrager JB: Complications of video-assisted thoracoscopic lung biopsy in patients with interstitial lung disease. The Annals of Thoracic Surgery 83(3): 1140-4, Mar 2007.
Munson JC, Kreider ME, Tino G: Idiopathic Pulmonary Fibrosis. BMJ Point-of-Care - www.pointofcare.bmj.com (Last accessed 10/2009) October 2009.
Munson JC, Kreider ME, Chen SA, Christie J, and Kimmel, SE : Factors Associated with Corticosteroid Therapy in Idiopathic Pulmonary Fibrosis. American Journal Respiratory and Critical Care Medicine 179(1): A4050, April 2009.
Munson JC, Kreider ME, Christie JD, Kimmel SE: The Effect of Treatment Guidelines on the Initial Management of Idiopathic Pulmonary Fibrosis. Pharmacoepidemiology and Drug Safety 18(Suppl 1): S144-145, August 2009.